Eikon Therapeutics Common Stock Overview

Eikon Therapeutics Common Stock EBIT

EBIT (Earnings Before Interest and Taxes) analysis for EIKN.

Quarterly EBIT

-$87.34M

As of Mar 31, 2026

Annual EBIT (TTM)

N/A

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin